China Feihe Has Room to Grow 2H Sales -- Market Talk

Dow Jones08-30

0804 GMT - China Feihe's 2H sales are likely to pick up, thanks to tailwinds including product launches and a higher birthrate in China, which bodes well the infant milk formula producer, CCB International analysts say. China Feihe's 1H net profit rose 11% on year due to better-than-expected gross profit expansion and a lower-than-expected selling expense ratio, they say. The brokerage raises its 2024 earnings forecast for the company by 4% to factor in better-than-expected 1H results and positive 2H margins assumptions. It upgrades the stock to outperform from neutral and lifts its target price to HK$4.50 from HK$3.40. Shares are 4.0% higher at HK$4.20.(amanda.lee@wsj.com)

 

(END) Dow Jones Newswires

August 30, 2024 04:04 ET (08:04 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment